Literature DB >> 8780538

Lung carcinoma in former smokers.

L Tong1, M R Spitz, J J Fueger, C A Amos.   

Abstract

BACKGROUND: A reduction in the risk of lung carcinoma and a lower death rate among former smokers (FS) compared with current smokers (CS) have been documented in numerous U.S. and international studies. The main objective of our study was to compare the differences in demographic and clinical characteristics in groups stratified by smoking status and gender to evaluate the effect of smoking history and cessation on age at lung carcinoma diagnosis and on specific histologic type.
METHODS: We conducted a cross-sectional study of lung cancer at The University of Texas M.D. Anderson Cancer Center from January 1986 to December 1990 and from January 1992 to December 1993. This study included 1039 patients age 19-88 with confirmed primary lung carcinoma who responded to self-administered risk factor questionnaires. Among them, 497 patients (47.83%) were CS, 444 patients (42.73%) were FS, 98 patients (9.43%) had never smoked (NS), and 840 patients (80.8%) were heavy smokers (more than 20 pack-years).
RESULTS: The median age at lung carcinoma diagnosis for FS was slightly later than that for CS. The histologic type of lung carcinoma for those who had quit smoking more than 20 years previously was not significantly different from that of NS, but was significantly different from that of CS (P < 0.05) and from those who quit smoking fewer than 10 years previously (P < 0.10). CS was a positive predictor for both small cell carcinoma (odds ratio [OR] = 8.79) and squamous cell carcinoma (OR = 2.11) and negatively associated with adenocarcinoma (OR = 0.50), whereas FS was a positive predictor only for small cell carcinoma (OR = 5.50). The variable of pack-years was negatively associated with adenocarcinoma and positively associated with small cell carcinoma in all patients combined and in women, and was also positively associated with squamous carcinoma in all patients after adjustment by smoking status.
CONCLUSIONS: These results indicate that smoking cessation or less life-time smoking exposure affects the distribution of specific histologic subtypes of lung cancer, especially for women, and that smoking cessation may postpone the age at which lung cancer occurs.

Entities:  

Mesh:

Year:  1996        PMID: 8780538     DOI: 10.1002/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

Review 1.  Detection of early lung cancer.

Authors:  J C Porter; S G Spiro
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Oral iloprost improves endobronchial dysplasia in former smokers.

Authors:  Robert L Keith; Patrick J Blatchford; John Kittelson; John D Minna; Karen Kelly; Pierre P Massion; Wilbur A Franklin; Jenny Mao; David O Wilson; Daniel T Merrick; Fred R Hirsch; Timothy C Kennedy; Paul A Bunn; Mark W Geraci; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

3.  Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.

Authors:  Robert L Keith; Vijaya Karoor; Anthony B Mozer; Tyler M Hudish; Mysan Le; York E Miller
Journal:  Lung Cancer       Date:  2010-01-29       Impact factor: 5.705

4.  Translating cancer 'omics' to improved outcomes.

Authors:  Emily A Vucic; Kelsie L Thu; Keith Robison; Leszek A Rybaczyk; Raj Chari; Carlos E Alvarez; Wan L Lam
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

5.  Twenty five year mortality and air pollution: results from the French PAARC survey.

Authors:  L Filleul; V Rondeau; S Vandentorren; N Le Moual; A Cantagrel; I Annesi-Maesano; D Charpin; C Declercq; F Neukirch; C Paris; D Vervloet; P Brochard; J-F Tessier; F Kauffmann; I Baldi
Journal:  Occup Environ Med       Date:  2005-07       Impact factor: 4.402

Review 6.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

7.  Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.

Authors:  Li Zhang; J Jack Lee; Hongli Tang; You-Hong Fan; Lianchun Xiao; Hening Ren; Jonathan Kurie; Rodolfo C Morice; Waun Ki Hong; Li Mao
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-31

Review 8.  Dietary agents for prevention and treatment of lung cancer.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2015-01-30       Impact factor: 8.679

9.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

10.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.